High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion

Vimentin is an intermediate filament protein, with a key role in the epithelial to mesenchymal transition as well as cell invasion, and it is often upregulated during cancer progression. However, relatively little is known about its regulation in cancer cells. Here, we performed an RNA interference screen followed by protein lysate microarray analysis in bone metastatic MDA-MB-231(SA) breast cancer cells to identify novel regulators of vimentin expression. Out of the 596 genes investigated, three novel vimentin regulators EPHB4, WIPF2 and MTHFD2 were identified. The reduced vimentin expression in response to EPHB4, WIPF2 and MTHFD2 silencing was observed at mRNA and protein levels. Bioinformatic analysis of gene expression data across cancers indicated overexpression of EPHB4 and MTHFD2 in breast cancer and high expression associated with poor clinical characteristics. Analysis of 96 cDNA samples derived from both normal and malignant human tissues suggested putative association with metastatic disease. MTHFD2 knockdown resulted in impaired cell migration and invasion into extracellular matrix as well as decreased the fraction of cells with a high CD44 expression, a marker of cancer stem cells. Furthermore, MTHFD2 expression was induced in response to TGF-β stimulation in breast cancer cells. Our results show that MTHFD2 is overexpressed in breast cancer, associates with poor clinical characteristics and promotes cellular features connected with metastatic disease, thus implicating MTHFD2 as a potential drug target to block breast cancer cell migration and invasion.

[1]  M. Waltham,et al.  Epidermal Growth Factor-Induced Epithelio-Mesenchymal Transition in Human Breast Carcinoma Cells , 2003, Laboratory Investigation.

[2]  H. Ford,et al.  Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression , 2010, Journal of Mammary Gland Biology and Neoplasia.

[3]  T. Ludwig,et al.  CD44 Variant Isoforms Promote Metastasis Formation by a Tumor Cell-Matrix Cross-talk That Supports Adhesion and Apoptosis Resistance , 2009, Molecular Cancer Research.

[4]  M. Hendrix,et al.  Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. , 1997, The American journal of pathology.

[5]  Z. Zehner,et al.  TGFbeta1 regulation of vimentin gene expression during differentiation of the C2C12 skeletal myogenic cell line requires Smads, AP-1 and Sp1 family members. , 2007, Biochimica et biophysica acta.

[6]  Erik W Thompson,et al.  Epithelial to mesenchymal transition and breast cancer , 2009, Breast Cancer Research.

[7]  J. Foidart,et al.  TRANSACTIVATION OF VIMENTIN BY BETA-CATENIN IN HUMAN BREAST CANCER CELLS , 2003, International Journal of Gynecologic Cancer.

[8]  D. Swandulla,et al.  CD44 and hyaluronan promote invasive growth of B35 neuroblastoma cells into the brain. , 2010, Biochimica et Biophysica Acta.

[9]  R. Goldman,et al.  Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  Eric S. Lander,et al.  Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.

[11]  T. Magin,et al.  Mutations in vimentin disrupt the cytoskeleton in fibroblasts and delay execution of apoptosis. , 2006, European journal of cell biology.

[12]  A. Satelli,et al.  Vimentin in cancer and its potential as a molecular target for cancer therapy , 2011, Cellular and Molecular Life Sciences.

[13]  Santhosh K. P. Kumar,et al.  Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. , 2006, The American journal of pathology.

[14]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[15]  C. Eaves,et al.  Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance. , 2010, Cancer research.

[16]  P M Steinert,et al.  Molecular and cellular biology of intermediate filaments. , 1988, Annual review of biochemistry.

[17]  M. Clarke,et al.  Cancer stem cells and tumor metastasis: first steps into uncharted territory. , 2007, Cell stem cell.

[18]  Matej Oresic,et al.  15‐Hydroxyprostaglandin dehydrogenase associates with poor prognosis in breast cancer, induces epithelial–mesenchymal transition, and promotes cell migration in cultured breast cancer cells , 2012, The Journal of pathology.

[19]  Arthur C. Sanderson,et al.  Bladder cancer SNP panel predicts susceptibility and survival , 2009, Human Genetics.

[20]  S. N. Murthy,et al.  Vimentin organization modulates the formation of lamellipodia , 2011, Molecular biology of the cell.

[21]  O. Kallioniemi,et al.  Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress , 2012, British Journal of Cancer.

[22]  R. Mackenzie,et al.  NAD-dependent methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase is the mammalian homolog of the mitochondrial enzyme encoded by the yeast MIS1 gene. , 1993, Biochemistry.

[23]  A. Børresen-Dale,et al.  Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines , 2009, Oncogene.

[24]  Meng Qiao,et al.  Quantitative proteomics study of breast cancer cell lines isolated from a single patient: Discovery of TIMM17A as a marker for breast cancer , 2010, Proteomics.

[25]  E. Dreher,et al.  Loss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast. , 2002, Oncology reports.

[26]  M. Guarino.  Epithelial-to-mesenchymal change of differentiation. From embryogenetic mechanism to pathological patterns. , 1995, Histology and histopathology.

[27]  S. Weiss,et al.  A Wnt–Axin2–GSK3β cascade regulates Snail1 activity in breast cancer cells , 2006, Nature Cell Biology.

[28]  O. Kallioniemi,et al.  Monensin Is a Potent Inducer of Oxidative Stress and Inhibitor of Androgen Signaling Leading to Apoptosis in Prostate Cancer Cells , 2010, Molecular Cancer Therapeutics.

[29]  P. V. van Diest,et al.  The origin of vimentin expression in invasive breast cancer: epithelial–mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? , 2005, The Journal of pathology.

[30]  S. Panini,et al.  A functional role for vimentin intermediate filaments in the metabolism of lipoprotein-derived cholesterol in human SW-13 cells. , 1992, The Journal of biological chemistry.

[31]  J. Mpindi,et al.  Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer , 2011, Oncogene.

[32]  J. Astola,et al.  Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues , 2008, Genome Biology.

[33]  J. Pelletier,et al.  Binding and interconversion of tetrahydrofolates at a single site in the bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase. , 1995, Biochemistry.

[34]  Stephen J Benkovic,et al.  Interaction of dihydrofolate reductase with methotrexate: Ensemble and single-molecule kinetics , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  P. Aspenström.  The mammalian verprolin homologue WIRE participates in receptor-mediated endocytosis and regulation of the actin filament system by distinct mechanisms. , 2004, Experimental cell research.

[36]  G. Sonenshein,et al.  NF‐κB and epithelial to mesenchymal transition of cancer , 2008, Journal of cellular biochemistry.

[37]  J. Massagué,et al.  Epithelial-Mesenchymal Transitions Twist in Development and Metastasis , 2004, Cell.

[38]  J. Foidart,et al.  Transactivation of Vimentin by β-Catenin in Human Breast Cancer Cells , 2003 .

[39]  A. Määttä,et al.  Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. , 2007, Biochemical and biophysical research communications.

[40]  J. Cerhan,et al.  Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[41]  Pekka Kohonen,et al.  Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis , 2010, Breast Cancer Research and Treatment.

[42]  Jae Hyuk Lee,et al.  CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion. , 2012, International journal of oncology.

[43]  T. Krieg,et al.  Fibroblast-matrix interactions in wound healing and fibrosis. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[44]  Gerhard Christofori,et al.  Mechanisms of Motility in Metastasizing Cells , 2010, Molecular Cancer Research.

[45]  R. Mackenzie,et al.  The expression of mitochondrial methylenetetrahydrofolate dehydrogenase-cyclohydrolase supports a role in rapid cell growth. , 2004, Biochimica et biophysica acta.

[46]  D. Ingber,et al.  Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts. , 1998, Journal of cell science.

[47]  T. Sjöblom,et al.  Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. , 2008, Oncogene.

[48]  J. Foidart,et al.  Vimentin contributes to human mammary epithelial cell migration. , 1999, Journal of cell science.

[49]  J. Nesland,et al.  Expression of Ephb2 and Ephb4 in breast carcinoma , 2008, Pathology & Oncology Research.

[50]  J. Massagué,et al.  Beyond tumorigenesis: cancer stem cells in metastasis , 2007, Cell Research.

[51]  Anton J. Enright,et al.  MicroRNA-9 Inhibition of Cell Proliferation and Identification of Novel miR-9 Targets by Transcriptome Profiling in Breast Cancer Cells* , 2012, The Journal of Biological Chemistry.

[52]  Wen-Lin Kuo,et al.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.

[53]  D. Larsimont,et al.  Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating–cancer stem cells: distinct, overlapping or same populations , 2011, Oncogene.